Todd D
Department of Medicine, University of Hong Kong, Queen Mary Hospital.
Ann Acad Med Singap. 1994 May;23(3):430-6.
Many primary gastrointestinal lymphomas (PGL) are treatable and carry a good prognosis, particularly of localized and of "low grade" malignancy. In general, the stomach is the most commonly involved site followed by the small and then large intestines. The incidence of gastric lymphoma may be on the rise, and the response of lymphoma arising from gastric Mucosa Associated Lymphoid Tissue (MALT) to treatment of the co-existing Helicobacter pylori infection has added a new dimension to the study of PGL. Most PGLs are histologically aggressive and those involving the intestines tend to present late. In a series of 425 adult Chinese patients with PGL seen in Hong Kong between 1975 and 1993, there were 230 males and 195 females with a median age of 53 years. Sites of involvement were the oesophagus in 3, the stomach in 238, small intestines in 131 and large intestines in 53. The majority were of diffuse large cell, small cell, mixed or immunoblastic histology (Working Formulation) and 90% were of B cell origin. At presentation 70.6% had stage II, IV disease (Manchester Classification) and 64.7% had B symptoms. The most common presenting clinical features were abdominal pain, gastrointestinal bleeding, anorexia, vomiting and weight loss. Perforation occurred in 76 patients. Surgery was carried out in 318 (74.8%), radiotherapy in 161 (37.9%) and all patients with advanced diseases received chemotherapy, with or without radiotherapy. The overall 5-year survival was 75% in patients with low grade histology and 70% in those with clinical stage I and II disease.(ABSTRACT TRUNCATED AT 250 WORDS)
许多原发性胃肠道淋巴瘤(PGL)是可治疗的,且预后良好,尤其是局限性和“低级别”恶性的淋巴瘤。一般来说,胃是最常受累的部位,其次是小肠,然后是大肠。胃淋巴瘤的发病率可能在上升,胃黏膜相关淋巴组织(MALT)淋巴瘤对并存的幽门螺杆菌感染治疗的反应为PGL的研究增添了新的维度。大多数PGL在组织学上具有侵袭性,累及肠道的那些往往就诊较晚。在1975年至1993年间于香港见到的425例成年中国PGL患者系列中,有230例男性和195例女性,中位年龄为53岁。受累部位为食管3例,胃238例,小肠131例,大肠53例。大多数为弥漫大细胞、小细胞、混合或免疫母细胞组织学类型(工作分类法),90%为B细胞起源。就诊时,70.6%有Ⅱ、Ⅳ期疾病(曼彻斯特分类法),64.7%有B症状。最常见的就诊临床特征是腹痛、胃肠道出血、厌食、呕吐和体重减轻。76例发生穿孔。318例(74.8%)接受了手术,161例(37.9%)接受了放疗,所有晚期疾病患者均接受了化疗,有或没有放疗。低级别组织学患者的总体5年生存率为75%,临床Ⅰ期和Ⅱ期疾病患者为70%。(摘要截短于250字)